Neuronetics (STIM) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -5

One insider bought $901K. No sales.

BuyJorey Chernett$41K10% ownerat $2.27 on Oct 30, filed today

BuyJorey Chernett10% owner$41Kat $2.27 on Oct 30, filed today

BuyJorey Chernett$44K10% ownerat $3.16 on Aug 14, filed Aug 17

BuyJorey Chernett10% owner$44Kat $3.16 on Aug 14, filed Aug 17

BuyJorey Chernett$62K10% ownerat $1.78 on Jul 14, filed Jul 15

BuyJorey Chernett10% owner$62Kat $1.78 on Jul 14, filed Jul 15

From SEC Form 4s, the newest filed Nov 2, 2026 · Insiders have 2 business days to file a trade

2 more filings on STIM in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 5 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on STIM with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about STIM's insider trades

As of Nov 2, 2026: Neuronetics (STIM) has 5 insider filings on record in the last 6 months, the newest filed Nov 2, 2026. Its Quality Score is -5 (Poor). Scores as of 9:30 PM ET, 15 minutes behind.

Are STIM insiders buying or selling?

One insider bought $901K across 5 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Jorey Chernett, 10% owner, bought $41K on Oct 30, 2026.

Who are STIM's biggest insider sellers?

No STIM insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an STIM insider last buy?

Jorey Chernett, 10% owner, bought STIM shares ($41K) on Oct 30, 2026, filed Nov 2, 2026, the newest insider buy on record.

Neuronetics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices. STIM is on this week's insider buys.